NO20034146L - Syntetiske peptider og fremgangsmåte for forebyggende og terapeutisk anvendelse i kreftinvasjon og metastase - Google Patents

Syntetiske peptider og fremgangsmåte for forebyggende og terapeutisk anvendelse i kreftinvasjon og metastase

Info

Publication number
NO20034146L
NO20034146L NO20034146A NO20034146A NO20034146L NO 20034146 L NO20034146 L NO 20034146L NO 20034146 A NO20034146 A NO 20034146A NO 20034146 A NO20034146 A NO 20034146A NO 20034146 L NO20034146 L NO 20034146L
Authority
NO
Norway
Prior art keywords
metastasis
cancer invasion
therapeutic use
preventive
synthetic peptides
Prior art date
Application number
NO20034146A
Other languages
English (en)
Norwegian (no)
Other versions
NO20034146D0 (no
Inventor
Matthias Rath
Alexandra Niedzwiecki
Shrirang Netke
Original Assignee
Matthias Rath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matthias Rath filed Critical Matthias Rath
Publication of NO20034146D0 publication Critical patent/NO20034146D0/no
Publication of NO20034146L publication Critical patent/NO20034146L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20034146A 2002-01-23 2003-09-17 Syntetiske peptider og fremgangsmåte for forebyggende og terapeutisk anvendelse i kreftinvasjon og metastase NO20034146L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35131702P 2002-01-23 2002-01-23
PCT/EP2003/000659 WO2003062413A1 (en) 2002-01-23 2003-01-23 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis

Publications (2)

Publication Number Publication Date
NO20034146D0 NO20034146D0 (no) 2003-09-17
NO20034146L true NO20034146L (no) 2003-10-28

Family

ID=27613485

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034146A NO20034146L (no) 2002-01-23 2003-09-17 Syntetiske peptider og fremgangsmåte for forebyggende og terapeutisk anvendelse i kreftinvasjon og metastase

Country Status (22)

Country Link
US (1) US8012935B2 (es)
EP (1) EP1468085B1 (es)
JP (1) JP2005515262A (es)
KR (1) KR20040077764A (es)
CN (2) CN1622992A (es)
AT (1) ATE425247T1 (es)
BR (1) BR0302819A (es)
CA (1) CA2472775A1 (es)
DE (1) DE60326539D1 (es)
EE (1) EE200400030A (es)
ES (1) ES2324027T3 (es)
HR (1) HRP20040732A2 (es)
IL (1) IL162714A0 (es)
LV (2) LV13289B (es)
MX (1) MXPA04007170A (es)
NO (1) NO20034146L (es)
NZ (1) NZ533738A (es)
PL (1) PL209827B1 (es)
RU (1) RU2346043C2 (es)
WO (1) WO2003062413A1 (es)
YU (1) YU76403A (es)
ZA (1) ZA200405328B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2856598B1 (fr) * 2003-06-25 2005-10-28 Inst Nat Sante Rech Med Peptides derives de la proteine mmp-2 et leur utilisation en immunotherapie antitumorale
JP4911950B2 (ja) * 2005-11-07 2012-04-04 晃 伊東 Ｍｍｐ−１の部分ペプチドを用いた癌浸潤・転移阻害薬
EP2403508B1 (en) * 2009-03-06 2015-10-28 Université Paris Descartes Method of treating cancer employing gingival fibroblast conditioned medium
US8593732B1 (en) * 2010-01-23 2013-11-26 Lightsmyth Technologies, Inc. Partially metallized total internal reflection immersion grating
US8003110B1 (en) * 2011-01-24 2011-08-23 Matthias W. Rath Metalloproteinase oligopeptides and their therapeutic use
EP2649985A1 (en) * 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis (III)
US20140017267A1 (en) * 2012-07-13 2014-01-16 Matthias W Rath Metalloproteinase oligopeptides and their therapeutic use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280106A (en) 1988-05-20 1994-01-18 Liotta Lance A Matrix metalloproteinase peptides: role in diagnosis and therapy
GB8817075D0 (en) * 1988-07-18 1988-08-24 Raychem Ltd Oscillation suppressor
US5646027A (en) * 1994-09-08 1997-07-08 Warner-Lambert Company Process for the production of gelatinase catalytic domain protein
ES2559317T3 (es) 1999-10-29 2016-02-11 Glaxosmithkline Biologicals Sa Péptidos antigénicos de Neisseria

Also Published As

Publication number Publication date
EP1468085B1 (en) 2009-03-11
PL209827B1 (pl) 2011-10-31
ES2324027T3 (es) 2009-07-29
ZA200405328B (en) 2006-03-29
RU2004125599A (ru) 2005-07-10
NZ533738A (en) 2006-03-31
JP2005515262A (ja) 2005-05-26
HRP20040732A2 (en) 2005-06-30
LV13289B (en) 2005-11-20
US20030139345A1 (en) 2003-07-24
PL371254A1 (en) 2005-06-13
MXPA04007170A (es) 2004-10-29
CN1622992A (zh) 2005-06-01
US8012935B2 (en) 2011-09-06
CA2472775A1 (en) 2003-07-31
ATE425247T1 (de) 2009-03-15
RU2346043C2 (ru) 2009-02-10
LV13419B (en) 2006-09-20
DE60326539D1 (de) 2009-04-23
KR20040077764A (ko) 2004-09-06
WO2003062413A1 (en) 2003-07-31
YU76403A (sh) 2006-05-25
CN101007844A (zh) 2007-08-01
EP1468085A1 (en) 2004-10-20
IL162714A0 (en) 2005-11-20
EE200400030A (et) 2004-04-15
NO20034146D0 (no) 2003-09-17
BR0302819A (pt) 2004-04-27

Similar Documents

Publication Publication Date Title
TW200501976A (en) Compositions containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto
MXPA04001033A (es) Compuesto de sanado para heridas y anti-cancer.
MX2009008270A (es) Polipeptido novedoso que tiene actividad anti-tumoral.
AR039231A1 (es) Agentes de union ox40r novedosos
ATE506375T1 (de) Gegen das c5-komponent des komplementsystems gerichtete antikörper und deren verwendung
HRP20050585A2 (en) Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof
DE60217507D1 (de) Peptide für die behandlung von tumoren und anderen zuständen, die das entfernen oder zerstören von zellen erfordern
NZ607892A (en) Tfpi inhibitors and methods of use
DE60138558D1 (de) Peptid aus hsp70 welches nk zellaktivtät stimuliert und seine verwendung
EP4306123A3 (en) Saposin-a derived peptides and uses thereof
NO20034146D0 (no) Syntetiske peptider og fremgangsmåte for forebyggende og terapeutisk anvendelse i kreftinvasjon og metastase
RU2014134287A (ru) Бифункциональный пептид
ATE531384T1 (de) Peptide aus dem plasminogenaktivator-hemmer 1 und ihre verwendung
BR0113147A (pt) Proteìnas e peptìdeos do estresse e métodos de uso dos mesmos
LT2004079A (en) Sythetic peptides and uses therof for the prevention and therapy of cancer invasion and metastasis
NO20016341L (no) Inhibitorer for integrinet <alfa>v<beta>6
ATE544779T1 (de) Neue, die migration dendritischer zellen induzierende polypeptide, sowie medikamente und pharmazeutische zusammensetzungen, die diese enthalten
WO2002053172A3 (en) Use of matrix metalloproteinase peptide substrate to lower the rate of extracellular matrix turnover
FR2781230B1 (fr) Derives de peptides utilisables comme inhibiteur selectif du site n-terminal de l'enzyme de conversion de l'angiotensine humaine
DE60331166D1 (de) Splice variante des menschlichen hypophysären wachstumshormons
Diamandis et al. Induction of Complement C3a Receptor
Fucase Purification and characterization of proteases inhibitors of Bitis gabonica rhinoceros venom with pharmacological potential
TH57872B (th) สารยับยั้งของอินทีกริน อัลฟานู เบตา6
WO2004016220A3 (en) Apicomplexan pathways, inhibitiors, and drug delivery
ATE400288T1 (de) Peptide mit hohem cysteingehalt

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application